Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • KenFlo1
    Junior Member
    • Mar 2010
    • 4

    #1

    Formal Introduction - Hello everybody (Windsor, Canada)

    Hello everybody! I stumbled on this site while doing research for a paper I am writing for a course I am taking for my MBA. I have been deep diving into many threads which contains a lot of information but being a newbie, it looks like I have a lot to learn. My paper is covering start-up companies (Pacific Bio, Helicos and one I just discovered Ion Torrent) and how these start-up's machines / technologies match up to already established companies (Roche, Illumina, etc) regarding third generation sequencing related to RNA/DNA. Looks like I will be spending a lot of time reading the various threads since this site looks like it is a one stop shop for information. If anybody has any personal experiences with these start-ups or can point me out to information that directly compares these machines, I would appreciate it. Thanks..

    Ken
  • takout
    Member
    • Jun 2009
    • 10

    #2
    if u finish ur paper can u share with me?
    these information you can find in JP Morgan Healthcare Conference as well as AGBT .
    I am from china if any question ini china maybe I can give u hand

    Comment

    • LisaOsborne
      Junior Member
      • Mar 2010
      • 3

      #3
      I can provide any background information that you require on Complete Genomics (client). My email address is [email protected].
      Best wishes,
      Lisa

      Comment

      • bysanimadhu
        Junior Member
        • Mar 2010
        • 4

        #4
        Hello from Uppsala

        Hello, I am Madhu from Uppsala University. I am doing my Phd in Uppsala. I am working on ChIP-Seq using SOLiD platform. I am not a bioinformatician but , want to learn basic bioinformatics. Hope this site will hel me.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        10 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        11 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Working...